STING1 and neoplasm: Moreover, cGAS-STING signaling pathway agonists can also be combined with radiotherapy, chimeric antigen receptor T Cell (CAR-T) therapy, oncolytic virus therapy to enhance tumor immunity and improve efficacy (225, 226).